Presentations Include Data from More than 35 NanoString-Related Abstracts Including 11 Using the GeoMx Digital Spatial Profiler
CAR-T Symposium Highlights Characterization of Cellular Therapy Products
“NanoString’s platforms provide critical insights in immunotherapy research, where understanding the interaction of the immune system and the tumor are critical,” said
Poster # 313: A phase 1 evaluation of tebotelimab, a bispecific PD-1 x LAG-3 DART® molecule, in combination with margetuximab in patients with advanced HER2+ neoplasms, poster presented by
Poster # 305: Technical considerations for normalizing digital spatial profiling data with multiple within-patient samples, poster presented by
Late Breaking Poster # 816: Evaluating the potential of harnessing anti-leukemia T cells for the treatment of T-ALL, poster presented by
Poster # 761: Potential predictive biomarkers of rapid progression and response to anti-PD1 treatment by gene profiling analysis in metastatic melanoma patients, poster presented by
Cellular Therapy symposium:
Please join us at our CAR-T Symposium and stop by the NanoString Virtual Booth to learn more about the latest tools and products available.
To learn more about NanoString’s GeoMx Digital Spatial Profiler, please visit https://www.nanostring.com/products/geomx-digital-spatial-profiler/geomx-dsp.
For more information, please visit www.nanostring.com.
Vice President, Investor Relations & Corporate Communications